{{Rsnum
|rsid=4555772
|Chromosome=5
|position=75006833
|Orientation=plus
|GMAF=0.4862
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 35.1 | 43.2 | 21.6
| HCB | 35.8 | 48.5 | 15.7
| JPT | 33.6 | 56.4 | 10.0
| YRI | 5.8 | 35.3 | 59.0
| ASW | 5.4 | 37.5 | 57.1
| CHB | 35.8 | 48.5 | 15.7
| CHD | 42.5 | 39.6 | 17.9
| GIH | 16.3 | 38.8 | 44.9
| LWK | 0.0 | 0.0 | 0.0
| MEX | 37.5 | 44.6 | 17.9
| MKK | 8.5 | 41.8 | 49.7
| TSI | 39.6 | 46.5 | 13.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23362303
  |Trait=Stearic acid (18:0) plasma levels
  |Title=Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
  |RiskAllele=A
  |Pval=4E-6
  |OR=.09
  |ORtxt=unit increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}